LifeTech Scientific Geçmiş Kazanç Performansı
Geçmiş kriter kontrolleri 1/6
LifeTech Scientific yıllık ortalama 14.1% oranında kazançlarını artırırken, Medical Equipment sektöründe kazançlar growing at 14.7% annual. Gelirler growing yılda ortalama 17% oranında artmaktadır. LifeTech Scientific'in özkaynak karlılığı 2.4% ve net marjı 19.4%'dir.
Anahtar bilgiler
14.1%
Kazanç büyüme oranı
13.8%
EPS büyüme oranı
Medical Equipment Sektör Büyümesi | 13.7% |
Gelir büyüme oranı | 17.0% |
Özkaynak getirisi | 2.4% |
Net Marj | 19.4% |
Son Kazanç Güncellemesi | 30 Jun 2024 |
Yakın geçmiş performans güncellemeleri
Recent updates
LifeTech Scientific Corporation (HKG:1302) Looks Just Right With A 29% Price Jump
Oct 02Some Confidence Is Lacking In LifeTech Scientific Corporation's (HKG:1302) P/E
Jul 05LifeTech Scientific's (HKG:1302) Soft Earnings Are Actually Better Than They Appear
Apr 25What LifeTech Scientific Corporation's (HKG:1302) P/E Is Not Telling You
Dec 25Returns On Capital At LifeTech Scientific (HKG:1302) Have Stalled
Nov 28At HK$2.37, Is LifeTech Scientific Corporation (HKG:1302) Worth Looking At Closely?
Nov 03Investors Met With Slowing Returns on Capital At LifeTech Scientific (HKG:1302)
Aug 17Is There Now An Opportunity In LifeTech Scientific Corporation (HKG:1302)?
Jul 18Investors Met With Slowing Returns on Capital At LifeTech Scientific (HKG:1302)
May 05Here's What To Make Of LifeTech Scientific's (HKG:1302) Decelerating Rates Of Return
Oct 14There's Been No Shortage Of Growth Recently For LifeTech Scientific's (HKG:1302) Returns On Capital
Jul 15Does LifeTech Scientific (HKG:1302) Deserve A Spot On Your Watchlist?
Jun 30A Look At The Fair Value Of LifeTech Scientific Corporation (HKG:1302)
Jun 15Returns At LifeTech Scientific (HKG:1302) Are On The Way Up
Apr 03Here's Why I Think LifeTech Scientific (HKG:1302) Is An Interesting Stock
Mar 15Is LifeTech Scientific Corporation (HKG:1302) Potentially Undervalued?
Jan 22Some Investors May Be Worried About LifeTech Scientific's (HKG:1302) Returns On Capital
Dec 19Here's Why I Think LifeTech Scientific (HKG:1302) Might Deserve Your Attention Today
Dec 06Is LifeTech Scientific (HKG:1302) A Risky Investment?
Nov 20An Intrinsic Calculation For LifeTech Scientific Corporation (HKG:1302) Suggests It's 34% Undervalued
Oct 12The Returns On Capital At LifeTech Scientific (HKG:1302) Don't Inspire Confidence
Sep 13Should You Be Adding LifeTech Scientific (HKG:1302) To Your Watchlist Today?
Aug 28What Is LifeTech Scientific Corporation's (HKG:1302) Share Price Doing?
Aug 13LifeTech Scientific's (HKG:1302) Returns On Capital Not Reflecting Well On The Business
Jun 08Here's Why I Think LifeTech Scientific (HKG:1302) Is An Interesting Stock
May 26Should You Investigate LifeTech Scientific Corporation (HKG:1302) At HK$4.14?
May 11LifeTech Scientific (HKG:1302) Could Easily Take On More Debt
Mar 31Shareholders Are Thrilled That The LifeTech Scientific (HKG:1302) Share Price Increased 274%
Feb 21Do Insiders Own Lots Of Shares In LifeTech Scientific Corporation (HKG:1302)?
Jan 26Does LifeTech Scientific's (HKG:1302) Statutory Profit Adequately Reflect Its Underlying Profit?
Dec 13Are Strong Financial Prospects The Force That Is Driving The Momentum In LifeTech Scientific Corporation's HKG:1302) Stock?
Nov 25Gelir ve Gider Dağılımı
LifeTech Scientific nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.
Kazanç ve Gelir Geçmişi
Tarih | Gelir | Kazançlar | G+A Giderleri | Ar-Ge Giderleri |
---|---|---|---|---|
30 Jun 24 | 1,281 | 249 | 459 | 327 |
31 Mar 24 | 1,274 | 256 | 437 | 313 |
31 Dec 23 | 1,267 | 263 | 415 | 298 |
30 Sep 23 | 1,224 | 297 | 399 | 258 |
30 Jun 23 | 1,182 | 331 | 382 | 219 |
31 Mar 23 | 1,139 | 328 | 365 | 214 |
31 Dec 22 | 1,097 | 325 | 348 | 208 |
30 Sep 22 | 1,058 | 314 | 329 | 195 |
30 Jun 22 | 1,019 | 303 | 311 | 181 |
31 Mar 22 | 972 | 298 | 297 | 164 |
31 Dec 21 | 925 | 292 | 283 | 146 |
30 Sep 21 | 878 | 307 | 320 | 164 |
30 Jun 21 | 830 | 322 | 356 | 183 |
31 Mar 21 | 736 | 269 | 342 | 175 |
31 Dec 20 | 642 | 216 | 327 | 167 |
30 Sep 20 | 638 | 176 | 302 | 150 |
30 Jun 20 | 633 | 136 | 277 | 133 |
31 Mar 20 | 651 | 132 | 288 | 137 |
31 Dec 19 | 669 | 129 | 299 | 141 |
30 Sep 19 | 644 | 138 | 276 | 137 |
30 Jun 19 | 618 | 146 | 252 | 132 |
31 Mar 19 | 588 | 134 | 239 | 124 |
31 Dec 18 | 557 | 121 | 226 | 115 |
30 Sep 18 | 518 | 134 | 196 | 96 |
30 Jun 18 | 480 | 147 | 165 | 76 |
31 Mar 18 | 445 | 155 | 151 | 69 |
31 Dec 17 | 409 | 163 | 138 | 62 |
30 Sep 17 | 391 | 171 | 138 | 61 |
30 Jun 17 | 373 | 178 | 139 | 59 |
31 Mar 17 | 363 | 162 | 136 | 58 |
31 Dec 16 | 353 | 146 | 133 | 58 |
30 Sep 16 | 336 | 201 | 126 | 55 |
30 Jun 16 | 319 | 256 | 119 | 52 |
31 Mar 16 | 315 | 129 | 120 | 50 |
31 Dec 15 | 312 | 2 | 121 | 47 |
30 Sep 15 | 304 | -41 | 123 | 42 |
30 Jun 15 | 296 | -84 | 125 | 38 |
31 Mar 15 | 289 | -83 | 135 | 35 |
31 Dec 14 | 283 | -81 | 145 | 33 |
30 Sep 14 | 280 | -151 | 151 | 35 |
30 Jun 14 | 258 | -209 | 139 | 34 |
31 Mar 14 | 248 | -89 | 130 | 33 |
31 Dec 13 | 231 | -66 | 115 | 31 |
Kaliteli Kazançlar: 1302 büyük bir tek seferlik zarar ile CN¥139.3M, 30th June, 2024 tarihine ait son 12 aylık mali sonuçları etkiliyor.
Büyüyen Kar Marjı: 1302 'nin mevcut net kar marjları (19.4%) geçen yılın (28%) değerinden daha düşüktür.
Serbest Nakit Akışı ve Kazanç Analizi
Geçmiş Kazanç Büyüme Analizi
Kazanç Eğilimi: 1302 şirketinin kazancı son 5 yılda yılda 14.1% oranında arttı.
Büyüme Hızlandırma: 1302 'in son bir yıldır negatif kazanç büyümesi oldu, bu nedenle 5 yıllık ortalamasıyla karşılaştırılamaz.
Kazançlar vs. Sektör: 1302 geçtiğimiz yıl negatif kazanç büyümesine ( -24.8% ) sahipti ve bu da onu Medical Equipment sektör ortalamasıyla ( -4.3% ) karşılaştırmayı zorlaştırıyordu.
Özkaynak Getirisi
Yüksek ROE: 1302 'nin Özsermaye Getirisi ( 2.4% ) düşük olarak değerlendiriliyor.